Spinogenix

Developer of therapeutics for brain injury and neurodegenerative diseases

placeSan Diego, California, United States calendar_todayFounded 2016 groups7 employees language spinogenix.com

Social engagement

Social engagement: 1.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

2 Jul 2026
Leadership hire
Spinogenix Scientific Advisory Board member
16 Jun 2026
Product launch
tazbentetol
4 Jun 2026
Event
FRAXA Research Foundation webinar on Fragile X Treatment pipeline
Coming soon